The RBI maintained the repo rate at 5.25% with a 'Neutral' stance. FY26 inflation is projected at a comfortable 2.1%, though Q4 may see a technical rise to 3.2%. GDP growth was revised upward to 7.4%.
Team Sahi
Market snapshot: The Reserve Bank of India’s Monetary Policy Committee (MPC) concluded its February 2026 review by maintaining the status quo on the policy repo rate at 5.25%. Governor Sanjay Malhotra highlighted a 'Goldilocks phase' for the Indian economy, characterized by resilient growth and benign core inflation. While headline inflation saw a technical uptick in the final quarter of FY26 due to base effects, the underlying price pressures—specifically core inflation excluding volatile components like food and fuel—remain well-contained at approximately 2.6%. This stability provides the central bank with significant maneuverability to manage liquidity while supporting a revised GDP growth forecast of 7.4% for the current fiscal year.
Summary: The RBI maintained the repo rate at 5.25% with a 'Neutral' stance. FY26 inflation is projected at a comfortable 2.1%, though Q4 may see a technical rise to 3.2%. GDP growth was revised upward to 7.4%.
The RBI's decision to maintain a neutral stance despite low core inflation signals a cautious approach toward global volatility. By keeping rates steady at 5.25% after a cycle of easing, the central bank is prioritizing the anchoring of long-term inflation expectations at the 4% target. For investors, this environment suggests a peak in the rate-cutting cycle for now, shifting the focus to credit growth and liquidity management. The upward revision in GDP growth to 7.4% underscores India's divergence from global sluggishness, supported by robust trade agreements and increased government capital expenditure.
The RBI's focus on 'muted' underlying pressures combined with higher growth forecasts paints a picture of macroeconomic resilience. As the new inflation series with base 2024=100 prepares for release on February 12, market participants should expect continued policy stability and a focus on financial inclusion through Mission SAKSHAM.
High Performance Trading with SAHI.
Related
Recent
Fed's 2026 Outlook: Economic Resilience Meets Persistent Inflationary Pressures
Geopolitical Brinkmanship: Trump-Iran Tensions and the Indian Market Outlook
Zydus Lifesciences Disrupts Respiratory Care with India’s First Drug-Free Device 'Pepair' at ₹990
Infosys Pivots to 'AI-First' Era: New Framework Targets $300 Billion Market Opportunity
Zydus Lifesciences Disrupts Respiratory Care with India’s First Affordable Drug-Free Device ‘PepairTM’ at ₹990